UBS Group’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,056
| Closed | -$4.93K | – | 9163 |
|
|
2024
Q2 | $4.93K | Buy |
+2,056
| New | +$4.93K | ﹤0.01% | 6879 |
|
|
2024
Q1 | – | Sell |
-78,125
| Closed | -$326K | – | 8842 |
|
|
2023
Q4 | $326K | Buy |
+78,125
| New | +$326K | ﹤0.01% | 4282 |
|
|
2023
Q3 | – | Sell |
-13
| Closed | -$365 | – | 8844 |
|
|
2023
Q2 | $365 | Buy |
+13
| New | +$365 | ﹤0.01% | 7189 |
|
|
2023
Q1 | – | Sell |
-55
| Closed | -$798 | – | 9371 |
|
|
2022
Q4 | $798 | Buy |
55
+15
| +38% | +$218 | ﹤0.01% | 8869 |
|
|
2022
Q3 | $1K | Buy |
+40
| New | +$1K | ﹤0.01% | 9002 |
|
|
2022
Q2 | – | Sell |
-159
| Closed | -$6K | – | 9947 |
|
|
2022
Q1 | $6K | Buy |
+159
| New | +$6K | ﹤0.01% | 7966 |
|
|
2021
Q4 | – | Sell |
-295
| Closed | -$21K | – | 9540 |
|
|
2021
Q3 | $21K | Buy |
295
+188
| +176% | +$13.4K | ﹤0.01% | 5990 |
|
|
2021
Q2 | $14K | Buy |
107
+92
| +613% | +$12K | ﹤0.01% | 6627 |
|
|
2021
Q1 | $2K | Sell |
15
-16
| -52% | -$2.13K | ﹤0.01% | 7620 |
|
|
2020
Q4 | $2K | Buy |
+31
| New | +$2K | ﹤0.01% | 7105 |
|
|
2020
Q3 | – | Sell |
-37
| Closed | -$3K | – | 7474 |
|
|
2020
Q2 | $3K | Sell |
37
-63
| -63% | -$5.11K | ﹤0.01% | 6710 |
|
|
2020
Q1 | $4K | Buy |
100
+96
| +2,400% | +$3.84K | ﹤0.01% | 6499 |
|
|
2019
Q4 | $0 | Sell |
4
-98
| -96% | – | ﹤0.01% | 7238 |
|
|
2019
Q3 | $7K | Buy |
102
+29
| +40% | +$1.99K | ﹤0.01% | 6389 |
|
|
2019
Q2 | $9K | Sell |
73
-11
| -13% | -$1.36K | ﹤0.01% | 6271 |
|
|
2019
Q1 | $14K | Sell |
84
-10
| -11% | -$1.67K | ﹤0.01% | 5771 |
|
|
2018
Q4 | $14K | Buy |
+94
| New | +$14K | ﹤0.01% | 6132 |
|